ZOMEDICA CORP (ZOM)
CA98980M1095 - Common Stock
ZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023
ZOM stock results show that Zomedica beat on revenue for the fourth quarter of 2023.
3 High-Reward Penny Stocks to Uncover Big Gains
Dive into the realm of high-reward penny stocks. The article gives the insights you need to spot quality plays and make informed decisions.
7 Penny Stocks to Buy on the Dip: February 2024
With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks.
3 Hidden-Gem Penny Stocks That Could Yield Life-Changing Wealth
Unlock the secret to wealth with insights on ZOM, SNDL, and BLDE. Discover how these penny stocks could redefine your future.
Zomedica says Q4 revenue is expected to be over $7M (NYSE:ZOM)
Zomedica expects strong revenue growth in 2023, with Q4 revenue projected to be over $7 million and total 2023 revenue expected to exceed $25 million.
3 Breakout Penny Stocks Primed for Massive Gains
Discover three penny stocks poised for breakout success in veterinary, liquor retail, and insurance sectors.
Budget Bets: Top 3 Penny Stocks with Potential for Explosive Growth
These cheap stocks offer investors an extreme risk to reward tradeoff, which might be worth considering for lucrative payoffs.
Zomedica buys Truforma platform developer Qorvo Biotech LLC (NYSE:ZOM)
Zomedica acquires Qorvo Biotechnologies to gain control over diagnostic platforms Omnia and TRUFORMA, aiming to enhance production and accelerate test...
Zomedica receives non-compliance notice from NYSE American (NYSE:ZOM)
Zomedica (ZOM) on Wednesday said it has received a notice from NYSE American that it is not in compliance with the continued listing standard, as its shares have been selling for...
7 Biotech Stocks to Sell in September Before They Crash & Burn
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues.
The 7 Most Promising Penny Stocks to Buy in May 2023
Although extremely low-priced securities often present high risk, these are the most promising penny stocks to buy in May.
Zomedica acquires Structured Monitoring Products (NYSE:ZOM)
Zomedica (ZOM) to acquire Structured Monitoring Products, the makers of VetGuardian zero-touch vital signs remote monitoring system, at a previously negotiated purchase price
7 Small-Cap Biotech Stocks with Massive Potential
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.
7 Best Penny Stocks Under $3 to Buy in April
If you have the audacity to consider ultra-speculative opportunities, these ideas for best penny stocks under $3 might be appealing.
Why Shares of Zomedica Were Zooming Monday
Investors bought back into the stock after it fell to its lowest point in two months.
Zomedica hires new finance chief (NYSE:ZOM)
Veterinary health company Zomedica (ZOM) has appointed Peter Donato as chief financial officer, effective March 16, 2023.Donato has over 30 years of public and private company experience...
Zomedica stock rises as prelim Q4 revenue soars, CEO eyes growth via acquisitions
Zomedica (ZOM) stock rose ~4% premarket on Thursday after the company said Q4 revenue is expected to grow 46% to 51% Y/Y, as per preliminary results, and CEO Larry Heaton noted...
PRTY Stock Alert: NYSE Halts Trading in Party City Amid Bankruptcy News
Party City (PRTY) stock halted trading this morning after the retail company filed for Chapter 11 bankruptcy protection.
Why Is Zomedica (ZOM) Stock Up Today?
Zomedica (ZOM) stock is on the rise Wednesday after the company signed a strategic restructuring agreement with Qorvo Biotechnologies.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!
Zomedica stock rises on taking control of Truforma products via licesing deal
Zomedica (ZOM) said it is restructuring its existing development and commercialization agreements with Qorvo Biotechnologies for the company's Truforma line of products
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning, investor! We're starting off Thursday with a breakdown of the biggest pre-market stock movers this morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning! It's time for a breakdown of the biggest pre-market stock movers for Tuesday and the news that has them moving.
Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined Revenues
ANN ARBOR, MI / ACCESSWIRE / August 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company, a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for the three and six month periods ended June 30, 2022. Amounts are presented under accounting principles generally accepted in the United States of America ("U.S. GAAP").
Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health
ANN ARBOR, MI / ACCESSWIRE / July 18, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that it had acquired substantially all the assets of Assisi Animal Health LLC ("Assisi").
Zomedica Announces New Global Manufacturing & Distribution Center
ANN ARBOR, MI / ACCESSWIRE / July 7, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, is expanding its manufacturing and distribution facility in Roswell Georgia, which will significantly increase capacity for production and distribution of its products.